LATEST ALERTS
While moving cannabis to a less-restrictive Schedule III will not legalise the recreational market at a federal level, it may reflect the need for authorities to modify their attitude to align with changes in society
The recent discovery of the illicit animal tranquilliser xylazine in cannabis vapes raises concerns about harmful contaminants. How do these substances end up in vaping products?
Canada’s cannabis industry is warning more cannabis companies may be forced to close their doors in the coming months, after the Canadian government failed to deliver excise duty relief in this year’s federal budget
In June 2022, the European Food Safety Authority broke some very bad news to CBD companies applying for their products to be authorised as novel food in the European Union
Malawi has legalised the cultivation of a potent local variety of cannabis for industrial and medicinal use but maintained the criminal status of its recreational use – raising concerns among the Rastafarian community
The reclassification of cannabis to a less restrictive schedule of the US Controlled Substances Act will have crucial implications for the industry, especially as far as taxation is concerned, experts say
UK-based CBD brands Cannaray and Pureis are the first to obtain a positive safety assessment from the Food and Standards Agency (FSA) Advisory Committee on Novel Foods and Processes
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
